BiotechTube
Home/Q32 Bio/Jodie Morrison
JM

Jodie Morrison

Chief Executive Officer and Member of the Board of Directors

Q32 Bio

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesAlopecia Areata

Q32 Bio Pipeline

DrugIndicationPhase
Bempikibart (ADX-914)Alopecia Areata (AA)Phase 2
ADX-096Complement-mediated diseasesDiscovery/Preclinical
C3d mAb fusionsComplement-mediated diseasesDiscovery/Preclinical
Complement-targeting nanobodiesComplement-mediated diseasesDiscovery/Preclinical

Leadership Team at Q32 Bio

SV
Shelia Violette, Ph.D.
Founder, Chief Scientific Officer and President of Research
LK
Lee Kalowski, M.B.A.
President and Chief Financial Officer
View full Q32 Bio profile